Dec 16, 2019 / 01:30PM GMT
Operator
Good morning. This is the operator, and we are ready to begin the call.
I would like to turn the call over to Taylor Crouch, President and CEO of Organovo.
Taylor J. Crouch - Organovo Holdings, Inc. - CEO, President & Director
Thank you, operator. Good morning, and welcome to our conference call which will provide an overview of the proposed merger between Organovo and Tarveda Therapeutics that was announced in a press release that was jointly issued earlier today.
Joining me on the call is the President, CEO and Chairman of Tarveda, Drew Fromkin, and we look forward to discussing with you what we believe to be an exciting development for both our companies.
The call will run as follows. I'll discuss the strategic process Organovo has undertaken to get us to the merger we announced today, provide my thoughts on why Tarveda is the right path forward for our company and our stockholders and touch on some of the key details of the proposed transaction. Drew will then share his perspective on this merger and the opportunity for
Organovo Holdings, Inc., Tarveda Therapeutics, Inc. - M&A Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers